Clinical trial
S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With…
NCT00003158 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003158 |
|---|---|
| Title | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer |
| Official title | A Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol) for Poor-Risk Stage III Non-Small Cell Lung Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, etoposide, paclitaxel, radiation therapy |
| Enrollment | 96 |
| Start date | Feb 1, 1998 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2007 |
| First posted | Aug 2, 2004 |
| Last update posted | Jul 24, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: